Berrevoet, F.
van Cauteren, L.
Gunja, N.
Danker, W. A. III
Schmitz, N.-D.
Tomaszewski, J.
Stern, L.
Chandak, A.
Funding for this research was provided by:
Ethicon (1472047)
Article History
Received: 4 December 2023
Accepted: 1 March 2024
First Online: 12 April 2024
Declarations
:
: This was a non-interventional retrospective study. The data obtained from the center for this study was de-identified and did not include any patient identifiers or dates, nor any attempt made to re-identify the patients. This study was approved by the Ethics Committee at University Hospital Gent (Commissie voor medische Ethiek, Universitair Ziekenhuis Gent) with the reference number “BC-09077”.
: FB reports consulting fees and honoraria from Johnson & Johnson (Ethicon) and also participated in advisory boards for Johnson & Johnson (Ethicon), Medtronic and Tissium. NG, WAD, NDS, and JT are employees of Johnson & Johnson (Ethicon). AC and LS are employees of Certara (which was contracted by Ethicon to conduct this study).
: Not applicable.
: For this type of non-interventional retrospective study using de-identified data, formal consent was not required.